| CIMCX | HRLSX | CIMCX / HRLSX | |
| Total Expense Ratio | 1.35 | 1.20 | 113% |
| Annual Report Gross Expense Ratio | 1.35 | 1.71 | 79% |
| Fund Existence | 25 years | 16 years | - |
| Gain YTD | 9.513 | 17.544 | 54% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 148B | 76.5M | 193,464% |
| Annual Yield % from dividends | 2.68 | 3.16 | 85% |
| Returns for 1 year | 7.80 | 25.14 | 31% |
| Returns for 3 years | 38.15 | 48.00 | 79% |
| Returns for 5 years | 25.07 | 55.40 | 45% |
| Returns for 10 years | 67.61 | 89.75 | 75% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SNOAX | 42.66 | -0.06 | -0.14% |
| Easterly Snow Long/Short Opportunity A | |||
| VYGNX | 13.18 | -0.06 | -0.45% |
| Voya Global Income & Growth R6 | |||
| IRTCX | 28.99 | -0.21 | -0.71% |
| Invesco Dividend Income R | |||
| VSGIX | 100.26 | -1.11 | -1.09% |
| Vanguard MStar Small Cap Growth Idx Inst | |||
| FTDZX | 221.59 | -5.52 | -2.43% |
| Franklin Biotechnology Discovery Adv | |||